AstraZeneca will demolish research labs in Delaware
AstraZeneca will tear down three research laboratory buildings at its headquarters in Fairfax, Delaware, as part of its global restructuring, according to delaware online.
The three buildings are a major part of the company's Fairfax unit and house all of the research efforts. Moroever, it’s only about a decade old.
Last year, AstraZeneca announced it would end research into new psychiatric medicines and close its Delaware labs as part of a global restructuring.
As a result, about 550 Delaware-based researchers have lost their jobs, reducing the company's employment here to 3,500, from a high of 5,000. AstraZeneca's Delaware employment is at its lowest point since 2004.
Employees will move drugs through to late-stage development, but all Delaware research operations will end by the end of 2011.